Business Description
![Xtacy Therapeutics Corp Xtacy Therapeutics Corp logo](https://static.gurufocus.com/logos/0C00006DZR.png?14)
Xtacy Therapeutics Corp
NAICS : 525990
SIC : 7129
ISIN : CA6993552026
Compare
Compare
Traded in other countries / regions
XTCY.CanadaXTCYF.USATT5.Germany IPO Date
2009-07-16Description
Xtacy Therapeutics Corp is a debt financing company. The company provides a debt financing facility to help companies build their valuation and get to the next level in its financing cycle without giving away equity prematurely in their growth cycle. It focuses on providing finance to medical cannabis, hemp, and CBD-related, healthcare-related target companies.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | -3.02 | |||||
Debt-to-Equity | -0.01 | |||||
Debt-to-EBITDA | -0.02 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -138.28 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -47.7 | |||||
3-Year EBITDA Growth Rate | 21.3 | |||||
3-Year EPS without NRI Growth Rate | 21.3 | |||||
3-Year FCF Growth Rate | 20.6 | |||||
3-Year Book Growth Rate | 27 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.8 | |||||
9-Day RSI | 33.43 | |||||
14-Day RSI | 38.4 | |||||
12-1 Month Momentum % | -20 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.22 | |||||
Quick Ratio | 0.22 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -49.4 | |||||
Shareholder Yield % | 0.09 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 93.48 | |||||
Operating Margin % | -1821.74 | |||||
Net Margin % | -947.83 | |||||
FCF Margin % | -254.35 | |||||
ROA % | -159.36 | |||||
ROIC % | -316.23 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 30 | |||||
EV-to-EBIT | -1.99 | |||||
EV-to-EBITDA | -1.99 | |||||
EV-to-Revenue | 36.15 | |||||
EV-to-FCF | -23.54 | |||||
Earnings Yield (Greenblatt) % | -50.34 | |||||
FCF Yield % | -7.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Xtacy Therapeutics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.046 | ||
EPS (TTM) (C$) | -0.011 | ||
Beta | -0.17 | ||
Volatility % | 119.66 | ||
14-Day RSI | 38.4 | ||
14-Day ATR (C$) | 0.003729 | ||
20-Day SMA (C$) | 0.0395 | ||
12-1 Month Momentum % | -20 | ||
52-Week Range (C$) | 0.02 - 0.115 | ||
Shares Outstanding (Mil) | 54.58 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Xtacy Therapeutics Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Xtacy Therapeutics Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Xtacy Therapeutics Corp Frequently Asked Questions
What is Xtacy Therapeutics Corp(XCNQ:XTCY)'s stock price today?
The current price of XCNQ:XTCY is C$0.03. The 52 week high of XCNQ:XTCY is C$0.12 and 52 week low is C$0.02.
When is next earnings date of Xtacy Therapeutics Corp(XCNQ:XTCY)?
The next earnings date of Xtacy Therapeutics Corp(XCNQ:XTCY) is .
Does Xtacy Therapeutics Corp(XCNQ:XTCY) pay dividends? If so, how much?
Xtacy Therapeutics Corp(XCNQ:XTCY) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |